Honey, I Shrunk the Pharmaceutical Industry

honey-i-shrunk-the-kids-
Image courtesy of FilmClub.org

More news this week about the Incredible Shrinking U.S. Pharmaceutical Industry. Yesterday, BioPharma Dive ran a story titled “3 Major Trends Driving Layoffs in Biotech and Pharma.” 

Jobs in the U.S. pharmaceutical industry have been eliminated at an alarming rate. Consider the most recent numbers. Between 2009 and 2013–a five year period–at least 156,000 American jobs were eliminated from pharmaceutical companies. One thing we’ve definitely learned over more than two decades working in the healthcare and pharmaceutical industries: just because something is good for shareholder return does not mean that it is healthy for the industry overall.

Continue reading

A Pause to Reflect

Park1

Early this morning, we took a pause to head to Jonathan Dickinson State Park in Hobe Sound to reflect and enjoy nature. I find creative inspiration in lots of places. It can be a city, a natural setting, a great conversation with an old friend, or just spending some quiet time with my daughter (if you want to see real creativity, play with a 10 year old for a while). On this Memorial Day weekend, I am grateful for this beautiful country we live in, and I am thankful to those who gave their lives so that we can enjoy the freedoms we have.

Continue reading

Communication and Content: Critical Ingredients for Patient Engagement

Doctor_patientPatient engagement is a hot topic as healthcare continues to be complex, and as technology increases the ability of medical practices to remain connected to their patients. In simple terms, patient engagement is about creating interventions that influence patient behavior and encourage positive changes (such as better diet, more exercise, quitting smoking) that lead to improved outcomes, better patient care, and lower costs. This is the “triple aim” of healthcare.

Continue reading

Accelerating Precision Medicine? Elementary My Dear Watson

Big-DataOne of my favorite life sciences industry media channels, BioPharma Dive, had a story this week about a new collaboration between IBM’s Watson Health division and 14 major oncology centers nationwide. The alliance is focused on bringing unprecedented analytics technology to cancer genomics.

The potential of this kind of collaboration on the growth of precision medicine, and its impact on the oncology market is exciting. Watson isn’t just for beating humans at Jeopardy!  It is now a core part of IBMs strategic vision in a number of different markets, including life sciences. Continue reading

The mHealth Market: 43% Growth Through 2019

mhealthThe mobile health market is hot. Consumer driven healthcare, an aging population, the proliferation of smart devices and greater connectivity than ever before have created the “perfect storm” where mhealth and technology driven diagnostic services are experiencing explosive growth.

The global mhealth and diagnostic medical device market is expected to grow at a CAGR of 43.3% between 2013 and 2019. That’s not just hot, that’s muy caliente.

Continue reading